CON Healthcare

Concentra Group Holdings Parent, Inc.

$40.15-0.45%

Price as of close on Nov 3, 2026 · Financials updated Oct 8, 2026

Basics

Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Market cap: 5.1B USD
Enterprise value: 6.3B USD
Full-time employees: 9,967

Overall health

Strength: growing faster than most peersgrowing faster than peers
Strength: its shares are priced lower than most peers relative to what it earnspriced lower than peers for its earnings
Drawback: higher risk than most peers: less short-term liquidity (current ratio 1.38 vs a peer median of 2.59) and more debt relative to equity (3.30× vs a peer median of 0.22×)higher risk: less liquidity (current ratio 1.38 vs peers 2.59) and more debt vs equity (3.30× vs peers 0.22×)

Ranks #523 of 1,157 healthcare companies (top 46%)

See how it ranks against its peers

Worth knowing

Much more borrowing than peers. Debt is 3.3× equity vs a peer median of 0.2×.Debt is 3.3× equity vs peers 0.2×.
Debt is 3.3× shareholders' equity, against a peer median of 0.2×, among the highest 10% of its peer group.Debt is 3.3× shareholders' equity, vs peers 0.2×, among the highest 10% of its peer group.
Profit is backed by cash. Free cash flow is 135% of reported profit.
Concentra Group Holdings Parent's free cash flow is 135% of its reported profit, so its earnings are turning into cash it can reinvest, pay out or use to reduce debt.

StockQuotient Score

54/ 100

Oct 5 55 → Nov 4 54 (-1)

Valuation

Is the price right?

66/100

Moderate

3/3 inputs reported · High confidence

Since last quarter: No major changeValuation also moves with the share price every day.

Why

Stronger than most peers on:

▲ Earnings yield
▲ EBITDA yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield3.9%

SEC filings · 12 months to Jun 2026Reported value30% base weight · Z-score 1.62Sector median: 0.0148 · MAD: 0.0148

EBITDA yield7.0%

SEC filings · 12 months to Jun 2026Reported value50% base weight · Z-score 0.74Sector median: 0.0401 · MAD: 0.0401

Free cash flow yield5.2%

SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingReported value20% base weight · Z-score 0.00Sector median: 0.0000 · MAD: 0.0000

Other data (not scored)

Book yield9.3%

SEC filings · latest balance sheetReported valueInformational · 0% composite weightSector median: 0.3716 · MAD: 0.2313

Growth

Is it growing?

63/100

Moderate

3/3 inputs reported · High confidence

Since last quarter: ▲ Stronger

12-month revenue up 2.5%

Why

Stronger than most peers on:

▲ EPS growth
▲ Revenue growth

Compare with peers

Behind the score

Revenue and earnings-per-share growth over one year, and revenue growth over three years.

Earnings per share growth33.8%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 0.80Sector median: 0.0976 · MAD: 0.2991

3-year revenue growth7.9%

Yahoo Finance fallback · SEC figure unavailable or out of date · 3 fiscal years to Dec 2025Reported value33% base weight · Z-score 0.24Sector median: 0.0584 · MAD: 0.0840

Revenue growth14.0%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 0.81Sector median: 0.0609 · MAD: 0.0974

Profitability

Does it earn well?

80/100

Strong

3/3 inputs reported · High confidence

Since last quarter: No major change

Why

Stronger than most peers on:

▲ ROA
▲ ROIC
▲ Operating margin

Compare with peers

Behind the score

Return on invested capital, operating margin, and return on assets.

Operating margin16.4%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 0.77Sector median: 0.0706 · MAD: 0.1217

Return on assets6.6%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 0.92Sector median: 0.0166 · MAD: 0.0537

Return on invested capital15.6%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score 1.09Sector median: 0.0471 · MAD: 0.1004

Other data (not scored)

Gross margin29.3%

Yahoo Finance fallback · SEC figure unavailable or out of date · trailing 12 monthsReported valueInformational · 0% composite weightSector median: 0.4697 · MAD: 0.2310

Return on equity41.7%

SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentileInformational · 0% composite weightSector median: 0.0330 · MAD: 0.1225

Risk

Debt, liquidity, price swings

Higher

Higher relative risk

3/3 inputs reported · High confidence

Since last quarter: No major change

Why

Weaker than most peers on:

▼ Debt / equity
▼ Current ratio

Compare with peers

Behind the score

Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.

Beta0.63

Yahoo Finance · 5-year monthly beta vs the marketReported value33% base weight · Z-score -0.00Sector median: 0.6250 · MAD: 0.3380

Current ratio1.38×

SEC filings · latest balance sheetReported value33% base weight · Z-score -0.87Sector median: 2.5860 · MAD: 1.3850

Debt / equity3.30×

SEC filings · latest balance sheetOutlier capped at sector 5th/95th percentile33% base weight · Z-score -9.77Sector median: 0.2215 · MAD: 0.2039

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Concentra Group Holdings Parent

Is Concentra Group Holdings Parent getting weaker?: Its latest SEC filing (Aug 6, 2026) showed no major changes. Its overall score is unchanged at 54/100 since Oct 28, 2026.
How is Concentra Group Holdings Parent valued vs its peers?: Priced lower than most peers relative to what it earns. Valuation scores 66/100 against 1,393 healthcare peers. Earnings yield 3.9% vs a peer median of 1.5% (stronger than 70% of peers).Earnings yield 3.9% vs peers 1.5% (stronger than 70% of peers).
Is Concentra Group Holdings Parent growing?: Yes, faster than most of its peers. Growth scores 63/100 against 1,393 healthcare peers. Earnings per share growth 33.8% vs a peer median of 9.8% (stronger than 75% of peers).Earnings per share growth 33.8% vs peers 9.8% (stronger than 75% of peers).
How profitable is Concentra Group Holdings Parent?: More profitable than most of its peers. Profitability scores 80/100 against 1,393 healthcare peers. Return on assets 6.6% vs a peer median of 1.7% (stronger than 80% of peers).Return on assets 6.6% vs peers 1.7% (stronger than 80% of peers).
How risky is Concentra Group Holdings Parent?: Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Debt / equity 3.30× vs a peer median of 0.22× (weaker than 100% of peers).Debt / equity 3.30× vs peers 0.22× (weaker than 100% of peers). A relative measure, not a bankruptcy probability.

Latest filing: what changed

Quarter ended Jun 30, 2026 · filed Aug 6, 2026 · compared with the quarter ended Mar 31, 2026

No major changes

	Previous quarter	Latest quarter	Change
Revenue (12 months)	2.2B USD	2.3B USD	+2.5%
Net income (12 months)	178.0M USD	198.7M USD	+11.7%
Operating margin	15.6%	16.4%	+0.7 pts
Free cash flow (12 months)	211.0M USD	267.4M USD	+26.7%
Debt	1.6B USD	1.6B USD	−0.2%
Cash	61.7M USD	158.0M USD	+156.1%
Shares outstanding	128.0M	127.5M	−0.3%

From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.

Industry valuation context

Industry: Medical Care Facilities · 27 companies

Valuations in Medical Care Facilities are within their usual range since Jun 2017.

39% of months since Jun 2017 were valued lower than now.
28% of companies are in the most expensive fifth of their own price-to-sales history.
Median price-to-sales is −61% vs the whole market, against a usual −56%.

Jun 2017Shaded: most expensive fifth of its range2026

Financials

Fiscal years from SEC annual filings · change vs the prior year

Key ratios	FY 2022	FY 2023	FY 2024	FY 2025	Change
Operating margin	15.0%	15.6%	16.0%	15.4%	▼ 0.6 pts
Net margin	9.7%	9.8%	8.8%	7.7%	▼ 1.1 pts
Return on assets (ROA)	7.3%	7.7%	6.6%	5.8%	▼ 0.8 pts
Return on equity (ROE)	17.0%	15.5%	60.4%	42.3%	▼ 18 pts
Free cash flow margin	13.2%	9.2%	11.1%	9.1%	▼ 2.0 pts
Current ratio	—	1.07×	1.42×	1.14×	▼ 20%
Debt to equity	—	0.00×	5.37×	4.00×	▼ 25%
Interest coverage	304.51×	1301.50×	6.39×	3.06×	▼ 52%

CON price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

BB Biotech AGBBZA.DE100/ 100

Arbutus Biopharma CorporationABUS97/ 100

Q32 Bio Inc.QTTB97/ 100

Bringing the fundamentals into focus…

Overall health

Strength: growing faster than most peersgrowing faster than peers

Strength: its shares are priced lower than most peers relative to what it earnspriced lower than peers for its earnings

Drawback: higher risk than most peers: less short-term liquidity (current ratio 1.38 vs a peer median of 2.59) and more debt relative to equity (3.30× vs a peer median of 0.22×)higher risk: less liquidity (current ratio 1.38 vs peers 2.59) and more debt vs equity (3.30× vs peers 0.22×)

Ranks #523 of 1,157 healthcare companies (top 46%)

See how it ranks against its peers

Worth knowing

Much more borrowing than peers. Debt is 3.3× equity vs a peer median of 0.2×.Debt is 3.3× equity vs peers 0.2×.

Debt is 3.3× shareholders' equity, against a peer median of 0.2×, among the highest 10% of its peer group.Debt is 3.3× shareholders' equity, vs peers 0.2×, among the highest 10% of its peer group.

Profit is backed by cash. Free cash flow is 135% of reported profit.

Concentra Group Holdings Parent's free cash flow is 135% of its reported profit, so its earnings are turning into cash it can reinvest, pay out or use to reduce debt.

Questions investors ask about Concentra Group Holdings Parent

Is Concentra Group Holdings Parent getting weaker?

Its latest SEC filing (Aug 6, 2026) showed no major changes. Its overall score is unchanged at 54/100 since Oct 28, 2026.

How is Concentra Group Holdings Parent valued vs its peers?

Priced lower than most peers relative to what it earns. Valuation scores 66/100 against 1,393 healthcare peers. Earnings yield 3.9% vs a peer median of 1.5% (stronger than 70% of peers).Earnings yield 3.9% vs peers 1.5% (stronger than 70% of peers).

Is Concentra Group Holdings Parent growing?

Yes, faster than most of its peers. Growth scores 63/100 against 1,393 healthcare peers. Earnings per share growth 33.8% vs a peer median of 9.8% (stronger than 75% of peers).Earnings per share growth 33.8% vs peers 9.8% (stronger than 75% of peers).

How profitable is Concentra Group Holdings Parent?

More profitable than most of its peers. Profitability scores 80/100 against 1,393 healthcare peers. Return on assets 6.6% vs a peer median of 1.7% (stronger than 80% of peers).Return on assets 6.6% vs peers 1.7% (stronger than 80% of peers).

How risky is Concentra Group Holdings Parent?

Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Debt / equity 3.30× vs a peer median of 0.22× (weaker than 100% of peers).Debt / equity 3.30× vs peers 0.22× (weaker than 100% of peers). A relative measure, not a bankruptcy probability.

Previous quarter

Latest quarter

Change

Revenue (12 months)

2.2B USD

2.3B USD

+2.5%

Net income (12 months)

178.0M USD

198.7M USD

+11.7%

Operating margin

15.6%

16.4%

+0.7 pts

Free cash flow (12 months)

211.0M USD

267.4M USD

+26.7%

Debt

1.6B USD

1.6B USD

−0.2%

Cash

61.7M USD

158.0M USD

+156.1%

Shares outstanding

128.0M

127.5M

−0.3%

Key ratios

FY 2022

FY 2023

FY 2024

FY 2025

Change

Operating margin

15.0%

15.6%

16.0%

15.4%

▼ 0.6 pts

Net margin

9.7%

9.8%

8.8%

7.7%

▼ 1.1 pts

Return on assets (ROA)

7.3%

7.7%

6.6%

5.8%

▼ 0.8 pts

Return on equity (ROE)

17.0%

15.5%

60.4%

42.3%

▼ 18 pts

Free cash flow margin

13.2%

9.2%

11.1%

9.1%

▼ 2.0 pts

Current ratio

—

1.07×

1.42×

1.14×

▼ 20%

Debt to equity

—

0.00×

5.37×

4.00×

▼ 25%

Interest coverage

304.51×

1301.50×

6.39×

3.06×

▼ 52%